Clinical Trial Update: Medication Treatment for Opioid Use Disorder in Expectant Mothers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a medication treatment for opioid use disorder in expectant mothers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome
• Opioid Use Disorder
• Substance Use Disorder

Snippet

Sponsor: T. John Winhusen, PhD | Conditions: Opioid-Related Disorders, Drug Addiction | Phase 3 | Status: COMPLETED